A reduction in the protein CD40, implicated in tolerance mechanisms and affinity maturation processes, was found in endogenous-EBV-infected cells in MS patients relative to healthy donors, but not in cells infected with the recombinant EBV strain B95.8 [20]. This evidence concerns the gene CD40 and myeloid sarcoma.